Safety and Efficacy of KPI-121 in Subjects With Postsurgical Inflammation and Pain

NCT02793817 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

520

Enrollment

INDUSTRY

Sponsor class

Conditions

Post Surgical Ocular Inflammation and Pain

Interventions

DRUG: KPI-121 1% Ophthalmic Suspension dosed BID
DRUG: Vehicle of KPI-121 Ophthalmic Suspension dosed BID

Sponsor

Kala Pharmaceuticals, Inc.